121 related articles for article (PubMed ID: 36765474)
1. [Effect and Mechanism of Atorvastatin on Reversing Drug Resistance in Leukemia by Regulating Glycolysis through PTEN/mTOR Pathway].
Liu M; Zhou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):38-44. PubMed ID: 36765474
[TBL] [Abstract][Full Text] [Related]
2. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Atorvastatin on Proliferation and Apoptosis of Leukemia Cell Line HL-60 and Its Mechanism of Signal Pathway].
Dai J; Liu T; Wang K; Pang YX; Wang Q; Chen ZZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):403-407. PubMed ID: 28446283
[TBL] [Abstract][Full Text] [Related]
4. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway.
Wang L; Tang B; Han H; Mao D; Chen J; Zeng Y; Xiong M
Cancer Biother Radiopharm; 2018 Feb; 33(1):32-38. PubMed ID: 29412697
[TBL] [Abstract][Full Text] [Related]
5. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells.
Wang JJ; Yu JP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176
[TBL] [Abstract][Full Text] [Related]
6. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of Apoptosis for Resveratrol-mediated Reversing the Drug-resistance of AML HL-60/ADR cells].
Guo YK; Shi M; Qin YL; Li YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):736-742. PubMed ID: 28641627
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of up-regulating PTEN gene on increasing the chemosensitivity in K562/ADM cells].
Zhang H; Yang LC; Cao LZ; Yang MH; Xie M; Zhu S; Zeng P; Yu Y
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):412-6. PubMed ID: 22781804
[TBL] [Abstract][Full Text] [Related]
9. L-securinine induces apoptosis in the human promyelocytic leukemia cell line HL-60 and influences the expression of genes involved in the PI3K/AKT/mTOR signaling pathway.
Han S; Zhang G; Li M; Chen D; Wang Y; Ye W; Ji Z
Oncol Rep; 2014 May; 31(5):2245-51. PubMed ID: 24676995
[TBL] [Abstract][Full Text] [Related]
10. HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia.
Zhou W; Xu S; Chen X; Wang C
Hematology; 2021 Dec; 26(1):170-178. PubMed ID: 33538241
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results indicate resveratrol affects proliferation and apoptosis of leukemia cells by regulating PTEN/PI3K/AKT pathway.
Meng J; Liu GJ; Song JY; Chen L; Wang AH; Gao XX; Wang ZJ
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4285-4292. PubMed ID: 31173300
[TBL] [Abstract][Full Text] [Related]
12. [Reversal Effect of Arctigenin on the Drug Resistance in Leukemia K562/A02 Cells and Its Mechanism].
Zou L; Fang Y; He W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):409-415. PubMed ID: 38660844
[TBL] [Abstract][Full Text] [Related]
13. [The Effect of si-PKM2 on Proliferation and Apoptosis of Acute Leukemic Cells and Its Molecular Mechanism].
Li LY; Nie ZY; Zhang XY; Luo JM; Yang L; Wang Q; Wang XZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1394-1402. PubMed ID: 34627416
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
16. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
Han GY; Cui JH; Liang S; Li HL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
[TBL] [Abstract][Full Text] [Related]
17. [Reversal Effect of Dihydromyricetin on Drug Resistance of K562/A02 Cell Line to Adriamycin].
Li BR; Wang L; Han WN; Xia LQ; Tang S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1369-1374. PubMed ID: 27784359
[TBL] [Abstract][Full Text] [Related]
18. PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway.
Cheng ZY; Guo XL; Yang XY; Niu ZY; Li SH; Wang SY; Chen H; Pan L
J Exp Clin Cancer Res; 2008 Dec; 27(1):87. PubMed ID: 19115995
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of PI3Kδ inhibitor idelalisib on proliferation of human myeloid leukemia cells and the reversal effect on drug resistance to adriamycin.
Li K; Yi P; Luo H; Li J; Meng L; Tang M; Zeng W; Yang S; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1389-1397. PubMed ID: 33472993
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effect of Baicalin and Adriamycin in Resistant HL-60/ADM Leukaemia Cells.
Zheng J; Asakawa T; Chen Y; Zheng Z; Chen B; Lin M; Liu T; Hu J
Cell Physiol Biochem; 2017; 43(1):419-430. PubMed ID: 28869936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
